Form 4: ENDRA Director Lou Basenese Receives Equity Grant

ENDRA Life Sciences Director Lou Basenese was granted 60,324 restricted stock units, aligning his interests with shareholders.

Summary

• Lou Basenese, a Director of ENDRA Life Sciences Inc. (NDRA), acquired 60,324 restricted stock units (RSUs).
• The RSUs convert to common stock on a one-for-one basis.
• The transaction date for the RSU grant was January 21, 2026.
• The RSUs will vest in full on January 21, 2027.
• Following this transaction, Mr. Basenese beneficially owns 65,709 securities, which includes unvested RSUs.
• The acquisition price for these RSUs was $0, which is typical for equity grants.

Sentiment

Score: 6

Explanation: The filing reports a standard equity grant to a director, which is generally viewed as a positive for aligning interests but does not indicate significant operational or financial news.

Positives

• The grant of restricted stock units to a director aligns management's interests with those of the shareholders, incentivizing long-term performance.
• Equity compensation is a common method to attract and retain qualified board members.

Negatives

• No direct negatives are apparent from this standard insider transaction report.

Risks

• The value of the RSUs is tied to the future performance of ENDRA Life Sciences Inc.'s common stock, exposing the director to market risk.

Future Outlook

The granted restricted stock units are scheduled to vest in full on January 21, 2027, indicating a future alignment of the director's compensation with the company's long-term performance.

Industry Context

The granting of restricted stock units to directors is a standard practice across various industries, particularly in life sciences and technology companies, to incentivize long-term commitment and align leadership interests with shareholder value creation.

Comparison to Industry Standards

• Equity compensation, such as restricted stock units, is a widely accepted form of director remuneration in publicly traded companies, consistent with corporate governance best practices.
• The vesting schedule, typically over one to three years, is common for such grants, aiming to retain directors and link their compensation to sustained company performance.

Related Party Transactions

• The acquisition of restricted stock units by Director Lou Basenese represents a transaction with a related party, which is a standard component of director compensation.

Stakeholder Impact

• Shareholders: The equity grant aligns the director's financial interests with those of the shareholders, potentially fostering decisions that enhance long-term shareholder value.
• Employees: While not directly impacting employees, such compensation practices can set a precedent for executive and board remuneration structures.

Next Steps

• The restricted stock units will vest in full on January 21, 2027, at which point they will convert to common stock.

Key Dates

Keywords

ENDRA Life Sciences, NDRA, Form 4, Restricted Stock Units, RSU, Equity Grant, Director Compensation, Insider Transaction, Lou Basenese